Primer group for one-step visual detection of novel coronavirus nucleic acid and kit thereof
A coronavirus and detection reagent technology, which is applied in the field of novel coronavirus detection, can solve the problems of long detection time, complex operation process, and increased pollution risk, and achieve the effects of short detection time, low equipment requirements, and pollution avoidance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0036] The method for preparing the primers is not particularly limited in the present invention, and conventional primer synthesis methods in the art can be used.
[0037]The present invention also provides a one-step visual detection kit for novel coronavirus, comprising the primer set and detection reagents, the detection reagents comprising enzyme detection mixture, guanidine hydrochloride and pH indicator; Includes Taq SSB.
[0038] In the present invention, the use concentrations of the F3, B3, FIP-1, BIP-1, FL-1 and BL-1 are preferably 1.5-2.5 μmol / L, 1.5-2.5 μmol / L, 15-17 μmol / L, respectively L, 15~17μmol / L, 0.3~0.5μmol / L and 0.3~0.5μmol / L, more preferably 1.8~2.2μmol / L, 1.8~2.2μmol / L, 15.5~16.5μmol / L, 15.5~16.5μmol / L, 0.35-0.45 μmol / L and 0.35-40.5 μmol / L, most preferably 2 μmol / L, 2 μmol / L, 16 μmol / L, 16 μmol / L, 0.4 μmol / L and 0.4 μmol / L. The present invention has no special limitation on the original concentration of the above-mentioned primers in the kit. When i...
Embodiment 1
[0059] Phenol Red-LAMP Visual Amplification Detection of Novel Coronavirus
[0060] 1. Primer design
[0061] A specific novel coronavirus loop-mediated isothermal amplification primer system was designed for the optimization of the N gene of the new coronavirus, and the primers were dissolved and diluted to the use concentration with nuclease-free ultrapure water. The primer sequences are as follows:
[0062] F3: ATTGAACCAGCTTGAGAGCA (SEQ ID No. 1);
[0063] B3: AATTTGCGGCCAATGTTTGT (SEQ ID No. 2);
[0064]FIP-1: TTGCCGAGGCTTCTTAGAAGCCAGGCCAACAACAAC AAGGC (SEQ ID No. 3);
[0065] BIP-1:AACACAAGCTTTCGGCAGACGTTGATTAGTTCCTGGT CCCCA (SEQ ID No. 4);
[0066] FL-1: AGCAGCAGATTTCTTAGTGACAGTT (SEQ ID No. 5);
[0067] BL-1: GGTCCAGAAACAAACCCAAGG (SEQ ID No. 6).
[0068] 2. Inspection process (such as figure 1 shown)
[0069] (1) Sample processing
[0070] Nasal / pharyngeal swab after sampling (nasal / pharyngeal swab is a nasal / pharyngeal swab dipped in pseudovirus solution) soa...
Embodiment 2
[0078] Detection of the effect of different concentrations of guanidine hydrochloride in the kit on the amplification efficiency
[0079] Construct and detect a 25 μL reaction system in a PCR reaction tube: 1 μL pseudovirus containing the N gene (20 copies / μL), 12.5 μL 2×enzyme detection mixture (40 mmol / L Tris-HCl, 20 mmol / L (NH 4 ) 2 SO 4 , 100mmol / LKCl, 16mmol / L MgSO 4 , 0.2% (v / v) Tween 20, 2.8mmol / L dNTP, 1.4mmol / L dUTP, 20U Bst2.0 WarmStart DNA Polymerase, 20U WarmStart RTx Reverse Transcriptase, 20U racilDNA Glycosylase, 3ng / μL Taq SSB, pH 8.8), 2.5 μL primer mixed solution (2 μmol / LF3 and B3, 16 μmol / LBIP-1 and FIP-1, 0.4 μmol / L FL-1 / BL-1); add 0, 10, 20, 30, 40, 50, 60 , 70 and 80 mmol / L guanidine hydrochloride (final concentration), 1 μL pH indicator (0.1% phenol red), supplemented with DEPC-H 2 O to a final volume of 25 μL / tube, centrifuge briefly, add 40 μL of mineral oil to each tube, and cap the tube tightly. Amplify in a constant temperature water bath or a...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com